Výsledky vyhledávání

Akademický článek

Final analysis of the phase 3 randomized clinical trial comparing HD201 vs. referent trastuzumab in patients with ERBB2-positive breast cancer treated in the neoadjuvant setting.

Autor: Pivot X; Institute of Cancer Strasbourg, 17 Rue Albert Calmette, 67033, Strasbourg, France. x.pivot@icans.eu., Manikhas AG; St Petersburg GBUZ City Clinical Oncology Dispensary, St Petersburg, Russia., Shamrai V; Vinnytsia Regional Clinical Oncological Dispensary, Vinnytsia, Ukraine., Dzagnidze G; S. Khechinashvili University Hospital, Tbilisi, Georgia., Soo Hoo HF; Penang General Hospital, Penang Island, Malaysia., Kaewkangsadan V; Department of Surgery, Phramongkutklao Hospital, Bangkok, Thailand., Petrelli F; Oncology Unit, ASST Bergamo Ovest, Bergamo, Trevigilio, Italy., Villanueva C; Clinique Clementville, Montpellier, Montpellier, France., Kim J; Prestige BioPharma Ltd, Singapore, Singapore., Pradhan S; Prestige BioPharma Ltd, Singapore, Singapore., Jaison L; Prestige BioPharma Ltd, Singapore, Singapore., Feyaerts P; Prestige BioPharma Ltd, Singapore, Singapore., Kaufman L; DICE, Naamloze Vennootschap, Dilbeek, Belgium., Derde MP; DICE, Naamloze Vennootschap, Dilbeek, Belgium., Deforce F; DICE, Naamloze Vennootschap, Dilbeek, Belgium., Cox DG; Institute of Cancer Strasbourg, 17 Rue Albert Calmette, 67033, Strasbourg, France.

Publikováno v: BMC cancer [BMC Cancer] 2023 Jan 31; Vol. 23 (1), pp. 112. Date of Electronic Publication: 2023 Jan 31.

Zobrazit plný text záznamu

Plný text ve formátu HTML

Akademický článek

Efficacy of HD201 vs Referent Trastuzumab in Patients With ERBB2-Positive Breast Cancer Treated in the Neoadjuvant Setting: A Multicenter Phase 3 Randomized Clinical Trial.

Autor: Pivot X; Institute of Cancer Strasbourg, Strasbourg, France., Georgievich MA; St Petersburg GBUZ City Clinical Oncology Dispensary, St Petersburg, Russia., Shamrai V; Vinnytsia Regional Clinical Oncological Dispensary, Vinnytsia, Ukraine., Dzagnidze G; S. Khechinashvili University Hospital, Tbilisi, Georgia., Soo Hoo HF; Penang General Hospital, Penang Island, Malaysia., Kaewkangsadan V; Department of Surgery, Phramongkutklao hospital, Bangkok, Thailand., Petrelli F; Oncology Unit, ASST Bergamo Ovest, Trevigilio, Bergamo, Italy., Villanueva C; Clinique Clementville, Montpellier, Montpellier, France., Nikolaevich LO; Republican Clinical Oncology Dispensary of Ministry of Health Bashkortostan Republic, Republic of Russia., Hii J; Prestige BioPharma Ltd, Singapore., Kim J; Prestige BioPharma Ltd, Singapore., Pradhan S; Prestige BioPharma Ltd, Singapore., Jaison L; Prestige BioPharma Ltd, Singapore., Feyaerts P; Prestige BioPharma Ltd, Singapore., Kaufman L; DICE, Naamloze vennootschap, Belgium., Derde MP; DICE, Naamloze vennootschap, Belgium., Bonamy GMC; Prestige BioPharma Ltd, Singapore., Deforce F; DICE, Naamloze vennootschap, Belgium., Cox DG; Institute of Cancer Strasbourg, Strasbourg, France.

Publikováno v: JAMA oncology [JAMA Oncol] 2022 May 01; Vol. 8 (5), pp. 698-705.

Zobrazit plný text záznamu

Akademický článek

A randomized phase I study comparing the pharmacokinetics of a bevacizumab (HD204) biosimilar to European Union- and United States of America-sourced bevacizumab.

Autor: Demarchi M; Paul Strauss Center, Strasbourg, France., Coliat P; Institut Cancérologie de Strasbourg (ICANS), Strasbourg, France., Barthelemy P; Institut Cancérologie de Strasbourg (ICANS), Strasbourg, France., Schott R; Paul Strauss Center, Strasbourg, France., BenAbdelghani M; Paul Strauss Center, Strasbourg, France., Kim M; Prestige BioPharma Ltd, Singapore, Singapore., Hii JCS; Prestige BioPharma Ltd, Singapore, Singapore., Feyaerts P; Prestige BioPharma Ltd, Singapore, Singapore., Ang FRX; Prestige BioPharma Ltd, Singapore, Singapore., Derde MP; DICE Cro bvba, Brussels, Belgium., Deforce F; DICE Cro bvba, Brussels, Belgium., Petit T; Paul Strauss Center, Strasbourg, France., Schwabe C; Auckland Clinical Studies, Auckland, New Zealand., Wynne C; Christchurch Clinical Studies Trust Ltd, Christchurch, New Zealand., Park LS; Prestige BioPharma Ltd, Singapore, Singapore., Pivot X; Institut Cancérologie de Strasbourg (ICANS), Strasbourg, France.

Publikováno v: PloS one [PLoS One] 2021 Sep 23; Vol. 16 (9), pp. e0248222. Date of Electronic Publication: 2021 Sep 23 (Print Publication: 2021).

Zobrazit plný text záznamu

Akademický článek

TROIKA-1: A double-blind, randomized, parallel group, study aimed to demonstrate the equivalent pharmacokinetic profile of HD201, a potential biosimilar candidate to trastuzumab, versus EU-Herceptin ^® and US-Herceptin ^® in healthy male subjects.

Autor: Demarchi M; Institute of Cancer Strasbourg (ICANS), Strasbourg, France., Coliat P; Institute of Cancer Strasbourg (ICANS), Strasbourg, France., Mclendon K; Royal Brisbane and Women's Hospital, Brisbane, Australia., Chung Shii Hii J; Prestige Biopharma Ltd, Singapore, Singapore., Feyaerts P; Prestige Biopharma Ltd, Singapore, Singapore., Ang F; Prestige Biopharma Ltd, Singapore, Singapore., Jaison L; Prestige Biopharma Ltd, Singapore, Singapore., Deforce F; DICE, NV, Brusseles, Belgium., Derde MP; DICE, NV, Brusseles, Belgium., Kim MJ; Prestige Biopharma Ltd, Singapore, Singapore.; Prestige Biologics Co Ltd, Seoul, Korea., Park LS; Prestige Biopharma Ltd, Singapore, Singapore.; Prestige Biologics Co Ltd, Seoul, Korea., Detappe A; Paul Strauss Cancer Center, Strasbourg, France., Pivot X; Institute of Cancer Strasbourg (ICANS), Strasbourg, France.; Paul Strauss Cancer Center, Strasbourg, France.

Publikováno v: Pharmacology research & perspectives [Pharmacol Res Perspect] 2021 Aug; Vol. 9 (4), pp. e00839.

Zobrazit plný text záznamu

Akademický článek

A method for determining potential parental contamination: linkage disequilibrium-based log-likelihood ratio analysis for IVF-PGT.

Autor: Bo, Le¹ (AUTHOR), Dong, Fangfang² (AUTHOR), Wu, Zhinan¹ (AUTHOR), Zhou, Anwen¹ (AUTHOR), Zhang, Yulan¹ (AUTHOR), Kong, Lingyin² (AUTHOR), Zhan, Lei¹ (AUTHOR), Lu, Naru² (AUTHOR), Qi, Lina² (AUTHOR), Sun, Tingting² (AUTHOR), Liang, Bo³ (AUTHOR) boliang880@alumni.sjtu.edu.cn, Mao, Caiping¹ (AUTHOR) maocaiping@suda.edu.cn

Publikováno v: Reproductive Biology & Endocrinology. 10/21/2024, Vol. 22 Issue 1, p1-12. 12p.

Zobrazit plný text záznamu

Plný text ve formátu HTML

Vergelijkende studie van dermato-cosmetische producten voor de droge tot zeer droge huid. Objectieve evaluatie aan de hand van efficiëntiemetingen

Autor: null DE PAEPE K, null ROSEEUW D, null DERDE MP, null ROGIERS V

Publikováno v: Tijdschrift voor Geneeskunde. 55:268-277

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::a77526eacc1f64a7a9aca91cc41a1ad6
https://doi.org/10.2143/tvg.55.4.5000358

Zobrazit plný text záznamu

Akademický článek

High‐risks drug adverse events associated with Cetirizine and Loratadine for the treatment of allergic diseases: A retrospective pharmacovigilance study based on the FDA adverse event reporting system database.

Autor: Kong, Weili¹ (AUTHOR), Dong, Yijun¹ (AUTHOR), Yi, Sixi¹ (AUTHOR), Mo, Wei¹ (AUTHOR), Yang, Hui¹ (AUTHOR) yh8806@163.com

Publikováno v: Clinical & Translational Allergy. Sep2024, Vol. 14 Issue 9, p1-10. 10p.

Zobrazit plný text záznamu

Plný text ve formátu HTML

Fiberoptic examination of the nasal cavity and nasopharynx in children

Autor: Derde Mp, Leonard Kaufman, Peter Clement, Deyun Wang

Publikováno v: International Journal of Pediatric Otorhinolaryngology. 24:35-44

In this prospective study, a flexible fiberoptic nasolaryngoscope with color video camera was used to examine the nasal cavity and nasopharynx in 180 pediatric patients. The relative size of the adenoid tissue was judged by endoscopy, which lead to a

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::35e664a1e1e17722633fea3cfb4379f7
https://doi.org/10.1016/0165-5876(92)90064-v

Zobrazit plný text záznamu

Evaluation of reflux episodes during simultaneous esophageal pH monitoring and gastroesophageal reflux scintigraphy in children

Autor: Piepsz A, Yvan Vandenplas, Derde Mp

Publikováno v: Journal of pediatric gastroenterology and nutrition. 14(3)

Gastroesophageal pH monitoring and reflux scintigraphy were simultaneously performed in 65 children, who were being investigated for suspected gastroesophageal reflux disease. The aim of the study was to compare, peak per peak, the information provid

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7dffff339e9fdf2a2aae15b244348dde
https://pubmed.ncbi.nlm.nih.gov/1619528

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání